Code of Maryland Regulations
Title 10 - MARYLAND DEPARTMENT OF HEALTH
Part 4
Subtitle 34 - BOARD OF PHARMACY
Chapter 10.34.28 - Automated Medication Systems
Section 10.34.28.10 - Quality Assurance Program

Universal Citation: MD Code Reg 10.34.28.10

Current through Register Vol. 51, No. 19, September 20, 2024

A. The responsible pharmacist, in consultation with the health care facility, a related institution as defined in Health-General Article, §19-301, Annotated Code of Maryland, or a medical facility owned and operated by a group model health maintenance organization as defined in Health-General Article, § 19.713.6, Annotated Code of Maryland, shall develop, maintain, and review annually a quality assurance program regarding the automated medication system that addresses, at minimum:

(1) A testing program which includes daily accuracy sampling that verifies the integrity of the system;

(2) Investigation of medication errors related to the automated medication system, and remedial actions taken;

(3) Review of discrepancies and transaction reports to identify patterns of inappropriate use and access;

(4) Review of the overall functioning of the system2;

(5) Security and access:

(6) Preventative maintenance;

(7) Sanitation;

(8) Storage conditions;

(9) Inventory of drugs;

(10) Drug procurement, delivery, and receipt;

(11) Record keeping;

(12) Proper labeling procedures; and

(13) Protocols in the event of a power outage or other situation in which the services of the system are interrupted, that include:
(a) A plan for insuring continuity of pharmacy services to patients; and

(b) A plan for system recovery.

B. The responsible pharmacist, in consultation with the health care facility, a related institution as defined in Health-General Article, §19-301, Annotated Code of Maryland, or a medical facility owned and operated by a group model health maintenance organization as defined in Health-General Article, § 19.713.6, Annotated Code of Maryland, shall develop, maintain, and review annually a quality assurance program regarding the remote or decentralized automated medication system that addresses, at a minimum, system override management to include:

(1) A list of medications that can be overridden which is limited to starter doses; and

(2) Review of system overrides to ensure appropriate utilization.

Disclaimer: These regulations may not be the most recent version. Maryland may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.